COMMUNIQUÉS West-GlobeNewswire

Akari Therapeutics CEO Highlights Differentiated ADC Payload Strategy and Path Toward Clinical Development in New CEO Corner
15/10/2026
CEO Abizer Gaslightwala discusses Akari’s novel PH1 payload strategy and execution priorities supporting AKTX-101’s advancement toward planned Phase 1 clinical development in mid-2027 Recent deal activity and emerging [...]
Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
15/10/2026
NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, announced today that it will present new research evaluating real-world outcomes [...]
Nanox Selected as One of TIME’s Best Inventions of 2026 for its Nanox.ARC X
15/10/2026
Nanox.ARC X recognized among the “world’s most groundbreaking innovations” and for its approach to making advanced medical imaging more accessible Marks Nanox’s second appearance on TIME’s Best Inventions list, and its [...]
Revolution Medicines’ RASONQUE™ (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer
15/10/2026
Recommendation based on results from Phase 3 RASolute 302 trial, which demonstrated a 60% reduction in risk of death compared with chemotherapy in the overall study population with statistically significant and [...]
Ambio Life Sciences Partners with Athletes for Care to Provide Medically Supervised Ibogaine Programming and Support to Professional Athletes Living with Traumatic Brain Injury
15/10/2026
• Mounting research links repeated head trauma in professional sports to lasting brain injury, with few effective treatment options for retired athletes • An initial cohort of three NHL and two NFL alumni independently [...]
A Child's Light Partners with coeo Therapy to Expand Rapid-Response Youth Trauma Care into Montgomery County
15/10/2026
The Strategic Regional Expansion Bridges Crucial Mental Health Access Gaps, Connecting Traumatized Youth with Relational, Whole-Person Healing Within Days COLLEGEVILLE, PA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- A Child's [...]
Selon un nouveau sondage commandé par la National Lung Health Alliance, les Canadiennes et les Canadiens appuient en forte majorité une loi pour une génération sans fumée (aussi appelée « génération sans tabac »)
15/10/2026
96 % des personnes sondées estiment qu’il est important d’éviter que les enfants ne commencent à fumer ou à vapoter, tandis que 76 % appuient l’initiative pour une génération sans fumée, cette même mesure audacieuse que [...]
Canadians Overwhelmingly Support a Smoke-Free Generation Law, a New Poll Commissioned by National Lung Health Alliance Finds
15/10/2026
96% say preventing children from taking up smoking or vaping is important, while 76% support a Smoke-Free Generation, the same bold action the U.K. passed into law OTTAWA, Ontario, Oct. 15, 2026 (GLOBE NEWSWIRE) -- A [...]
Chiesi Global Rare Diseases Supports Continued Generation of Real-World and Scientific Evidence in Epidermolysis Bullosa (EB), Including New Data Presented at 2026 PeDRA Annual Conference
15/10/2026
-- New mechanistic research and clinician-reported real-world experience adds to the evolving evidence base for birch triterpenes in EB -- -- Chiesi proudly marks EB Awareness Week (October 25–31) with continued [...]
Chiesi Global Rare Diseases Supports Continued Generation of Real-World and Scientific Evidence in Epidermolysis Bullosa (EB), Including New Data Presented at 2026 PeDRA Annual Conference
15/10/2026
-- New mechanistic research and clinician-reported real-world experience adds to the evolving evidence base for birch triterpenes in EB -- -- Chiesi proudly marks EB Awareness Week (October 25–31) with continued [...]
Neumarker and Cortica Enter Strategic Partnership to Advance Precision Autism Care
15/10/2026
Strategic Collaboration Focused on Precision Autism Care Partnership Brings Together Neumarker’s AI Platform and Cortica’s Clinical Expertise MOUNTAIN VIEW, Calif. and SAN DIEGO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- [...]
NHS Announces £838m GP IT Framework
15/10/2026
15 October 2026 DXS INTERNATIONAL PLC (AQSE: DXSP) NHS Announces £838m GP IT Framework DXS International plc ( AQSE: DXSP ), the UK healthcare technology provider, welcomes the announcement from NHS England which has [...]
Correction: DXS International PLC (AQSE: DXSP) NHS Announces £838m GP IT Framework
15/10/2026
15 October 2026 DXS INTERNATIONAL PLC (AQSE: DXSP) NHS Announces £838m GP IT Framework DXS International plc ( AQSE: DXSP ), the UK healthcare technology provider, welcomes the announcement from NHS England which has [...]
Profusa Receives ISO 13485:2016 Certificate from GMED
15/10/2026
Providing a Foundational Quality Management System (QMS) for Commercialization Certificate issued by GMED, an EU MDR notified body, following the positive certification decision previously announced ISO 13485 [...]
Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome
15/10/2026
Over 80% of assessed basal cell carcinoma lesions regressed across three Gorlin syndrome patients treated with KB113 Substantial regression was observed in lesions not directly injected with KB113, consistent with [...]
Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes
15/10/2026
Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes The Phase 1 trial will assess the safety and clinical [...]
OMass Therapeutics Announces $310 Million Series C Financing to Advance Portfolio of Small Molecule Therapeutics in Endocrinology and Immunology
15/10/2026
Financing co-led by new investors Bain Capital Life Sciences, Forbion and Novo Holdings, with strong participation from additional new and existing investors Proceeds to advance MC2 receptor antagonist OMS1620 through [...]
R1 Therapeutics to present Phase 2b trial-in-progress poster for AP306 at ASN Kidney Week 2026
15/10/2026
Poster will outline the design of R1’s ongoing global Phase 2b trial evaluating AP306 in patients with hyperphosphatemia AP306 is a potential first-in-class, oral, non-binder small molecule designed to inhibit all three [...]
Eclipse Life Sciences Announces Positive Topline Results from Phase 2 BETTIS-1 Study Evaluating EC-104 for Diabetic Macular Edema (DME)
15/10/2026
RESEARCH TRIANGLE PARK, N.C., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Eclipse Life Sciences, Inc. , a privately held clinical-stage biopharmaceutical company developing next-generation therapies for retinal diseases, today [...]

Pages